# Smith & Nephew

> Smith & Nephew is a VC fund in London backing Medical Device and Medical. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 5
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/smith-&-nephew
- X (Twitter): http://twitter.com/smithnephewplc
- Website: http://global.smith-nephew.com
- Facebook: http://www.facebook.com/SmithNephewplc

Smith & Nephew is a VC fund in London focused on Medical Device and Medical. Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

## Contacts

5 contacts available for Smith & Nephew. Shizune tracks 7 team members at Smith & Nephew. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/smith-nephew?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $2.7M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 4 | 80% |
| Medical | 3 | 60% |
| Health Care | 3 | 60% |
| Biotechnology | 3 | 60% |
| Manufacturing | 2 | 40% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Series C | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| Israel | 1 | 20% |
| United Kingdom | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Elga Lohler | Chief Human Resources Officer | 0 | https://shizune.co/investors/profile/elga-lohler |
| Jyothi Hartley | HR Global Category Lead, Indirect Procurement | 0 | https://shizune.co/investors/profile/jyothi-hartley |
| Namal Nawana | Chief Executive Officer | 0 | https://shizune.co/investors/profile/namal-nawana |
| Nasreen Jacobson | Senior Director R&D Fort Worth | 0 | https://shizune.co/investors/profile/nasreen-jacobson |
| Richard DeSchutter | Lead Director | 0 | https://shizune.co/investors/profile/richard-deschutter |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Miach Orthopaedics | Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts. | $30M | Series B | Jan 25, 2023 |  |
| Trice Medical | Trice Medical is founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physician's office. Their mission is to provide more immediate anddefinitive patient care, eliminating the false reads associated with current indirect modalities and significantly reducing the overall cost to the healthcare system.Trice Medical was founded in 2011 and is based in Pennsylvania. |  | Series C | Jan 14, 2019 |  |
| OrthoSpace | OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion. | $7M |  | Dec 01, 2016 |  |
| OrthoSpace | OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion. | $8M |  | May 19, 2015 |  |
| Michelson Diagnostics | Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more. | $2.7M | Series B | Feb 16, 2015 |  |

5 of 5 investments shown.

## Co-investors
- [HealthpointCapital](https://shizune.co/investors/profile/healthpointcapital) — VC Fund, 2 deals together
- [Triventures](https://shizune.co/investors/profile/triventures) — VC Fund, 2 deals together
- [Amzak Health Investors](https://shizune.co/investors/profile/amzak-health-investors) — VC Fund, 1 deal together
- [BioStar Capital](https://shizune.co/investors/profile/biostar-private-equity) — VC Fund, 1 deal together
- [Charter Capital Partners](https://shizune.co/investors/profile/charter-capital) — VC Fund, 1 deal together
- [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [F6 Ventures](https://shizune.co/investors/profile/flat6labs) — VC Fund
- [Oqal](https://shizune.co/investors/profile/oqal) — VC Fund
- [Alesta Yatırım](https://shizune.co/investors/profile/alesta-girisim) — VC Fund

## Featured in investor lists
- [Medical Investors in Israel](https://shizune.co/investors/medical-investors-israel)
- [Medical VC Funds in Israel](https://shizune.co/investors/medical-vc-funds-israel)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)

## FAQ

### What does Smith & Nephew invest in?

Smith & Nephew invests primarily in Medical Device, Medical and Health Care startups, most often at Series B and Series C stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Smith & Nephew's check size?

Smith & Nephew typically joins rounds of $2.7M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Smith & Nephew participates in.

### How do I contact Smith & Nephew?

Public channels for Smith & Nephew include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Smith & Nephew?

The team at Smith & Nephew includes Elga Lohler (Chief Human Resources Officer), Jyothi Hartley (HR Global Category Lead, Indirect Procurement) and Namal Nawana (Chief Executive Officer), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co